Navigation Links
Misperceptions About Smoking Cessation Aids May Hinder Smokers From Using Effective Treatment for Quitting
Date:2/29/2008

o quit cold turkey are successful long-term.(4) Tools for cessation such as NRT products are among the first-line treatments recommended for all smokers and when used as directed, can significantly increase a smoker's chances of quitting versus cold turkey and remaining smoke-free long-term (6 months and longer).(2,4) Over 100 clinical trials involving over 35,000 participants and extensive consumer use over more than 20 years have proven the safety and efficacy of NRT when used as directed.(5)

Researchers at the SRNT conference will review the detailed results at the following time:
-- Oral Presentation: Smokers' Views on the Safety of Nicotine Replacement

Therapy -- An Opportunity for Education?

* Date: Saturday, March 1

* Time: 10:00 a.m. -- 11:30 a.m. PST

About the Study

A survey of 900 men and women adult smokers in the U.S. was fielded in July 2007 by Richard Day Research through an online panel, screening for adults age 18 and over who smoke cigarettes every day. The survey was fielded to determine what smokers currently understand about their risks of smoking, effects of nicotine and smoking cessation treatments. The data was weighted to adjust for age, ethnicity and gender using estimates from the 2006 National Health Interview Survey. The "average" respondent in the survey was 48 years of age and started smoking when they were 16 years old, smokes 20 cigarettes per day and has tried to quit three times in the past (16 percent of respondents have never tried to quit). The survey was conducted on behalf of The American Legacy Foundation and GlaxoSmithKline Consumer Healthcare the industry leader in smoking cessation.

About GlaxoSmithKline Consumer Healthcare

GlaxoSmithKline (GSK) Consumer Healthcare is one of the world's largest over-the-counter consumer healthcare products companies. GSK offers the widest range of proven NRT products available, products which can significantly improve
'/>"/>

SOURCE GlaxoSmithKline Consumer Healthcare
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. The Diabetes Series 2008: Experts Speak About Developing Diabetes Therapeutics
2. Montana State University lab gives early warnings about biological invaders
3. Bio-Identical Hormone Menopause Doctor Responds to Recent FDA News About Estriol
4. U.S. District Court Decision About Eisais Legal Action Over Aricept ODT(R) ANDA Filing
5. Actress Aida Turturro Tells Americans to Start Now to Talk With Their Healthcare Provider About Taking Control of Their Diabetes
6. Varian Medical Systems Sponsors Special Broadcast of The Group Room(R), a Live Radio Talkshow About Cancer
7. Stevens researchers provide new information about mass spectrometry
8. MultiVu Video Feed: Allergan, Inc. Partners With "Project Runway" Designer Kara Saun and Gen Art Fresh Faces In Fashion to Raise Awareness About Excessive Underarm Sweating
9. Evotec Starts Phase II in Smoking Cessation with EVT 302
10. Laser Therapy Gives Smokers Hope for Successful New Years Resolution
11. Malaysia Genome Institute Advances Bioinformatics Research Using SGI Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2008)...YNBROOK, N.Y., Nov. 20 B...d: BSTC), a biopharmaceutical company,developing ...nnounced that,BioSpecifics, President, Thomas Weg...0th Annual Health Care Conference on Tuesday, Dece... Hotel in New York, NY. , A live webcast of...
(Date:11/20/2008)...ADISON, N.J., Nov. 20 At...SE: WYE ), held today, a dividend of fifty cents...ferred Stock was declared,payable on January 2, 2...ness,on December 12, 2008. , Wyeth is one ...cal and,health care products companies. It is a ...
(Date:11/20/2008)...RCHARD PARK, N.Y., Nov. 20 /PRNewswire-FirstCall/ ...unced effective today it will reduce its workforce... Dave DiGiacinto, President and Chief Operating Of...cessary action to reduce our cost structure to con...financial condition as we discussed in our recentl...
(Date:11/20/2008)...EATTLE, Nov. 20 IDRI (Infectious D.... announced today that they have entered into,an ... granted a worldwide,exclusive license for the re...I,s Glycopyranosyl Lipid Adjuvant (GLA) technology...Focusing on its mission to fight infectious diseas...
Breaking Biology Technology:MINRAD International, Inc. Announces Reduction in Workforce 2IDRI and Immune Design Corp. Enter License Agreement on GLA Vaccine Adjuvant 2
...n judgment against Morgan Stanley in the Ronald Pe...organizations e-mail message retention policies. ...e: , , The financial services firm Morgan Stanley ..., Morgan Stanley could not reliably produce e-mail... Morgan Stanley deliberately violated her orders ,...
...aches courses on early-stage companies at the Mass...ounded three venture capital funds. He was a self-...is sword, declining to raise new money for his fun...few deals. Theres nowhere for all that money to go...ote in Technology Review last month. Ill miss it. ...
..., the last time the Biotechnology Industry Organiz...lphia, about 3,700 people attended. A decade later...descend on the City of Brotherly Love. , ,As much ...ir sprawling convention hall and other civic impro...more about the growth of the global biotech indust...
...ation technology professionals in Wisconsin announ...chnology Association of Wisconsin, a forum for in...that generates more than $14B in revenue and hires...ders. , ,The association has 30 founding members, ...he rest are a mix of law, investment, utility and ...
Other Biology Technology:$1.45 billion judgment against Morgan Stanley sends message revisit e-mail retention policies 2$1.45 billion judgment against Morgan Stanley sends message revisit e-mail retention policies 3Is venture capital dead? No, but its beginning a new cycle 2Is venture capital dead? No, but its beginning a new cycle 3Wisconsin can shine in the competitive biotech world, even among the giants 2Wisconsin can shine in the competitive biotech world, even among the giants 3Statewide IT association will address IT issues and priorities 2Statewide IT association will address IT issues and priorities 3
(Date:11/21/2008)... Cardiovascular conditions leading to heart attack...mmon cancers of the prostate, breast or lung, but ...mechanisms at the molecular level. This in turn pr...cancer and cardiovascular diseases, but requires r...er. The seeds were sown for closer cooperation bet...
(Date:11/20/2008)...ompany Experiences Record Revenue Growth from Oper...Nov. 19 bioMETRX, Inc. (...consumer-based finger recognition products, today ...ing September 30, 2008. , , -- Revenues for... a 430% increase over second quarter revenues of $...
(Date:11/20/2008)... NanoMedical Systems Inc., (NMS), an Austin-based ...University of Texas Health Science Center at Houst...f anti-cancer agents and other medications, has re...rd through the Texas Emerging Technology Fund (ETF...the ETF awards, which were announced by Texas Gov....
(Date:11/20/2008)... CHICAGO -- The body,s immune system hates strange... it annihilates it. , This is the problem when p...l transplantation. The islet cells from a donor pa...ecipient -- often permitting independence from ins...kill the new hard-working islets. , A person who...
Breaking Biology News(10 mins):Mechanisms of cardiovascular disease and cancer give clues to new therapies 2Mechanisms of cardiovascular disease and cancer give clues to new therapies 3bioMETRX, Inc. Highlights 3rd Quarter 2008 Financial Results 2Texas invests record $3.5 million in startup cofounded by UT's Mauro Ferrari 2New technique eliminates toxic drugs in islet transplant in diabetic mice 2QLT reduces workforce as first step in its strategic restructure 9752 1QLT reduces workforce as first step in its strategic restructure 9752 2QLT reduces workforce as first step in its strategic restructure 9752 3The Lancet Publishes Vasogens ACCLAIM Results 2654 1The Lancet Publishes Vasogens ACCLAIM Results 2654 2The Lancet Publishes Vasogens ACCLAIM Results 2654 3The Lancet Publishes Vasogens ACCLAIM Results 2654 4The Lancet Publishes Vasogens ACCLAIM Results 2654 5Amarin Provides Business Update and Announces Implementation of Reverse Stock Split 2652 1Amarin Provides Business Update and Announces Implementation of Reverse Stock Split 2652 2Amarin Provides Business Update and Announces Implementation of Reverse Stock Split 2652 3Amarin Provides Business Update and Announces Implementation of Reverse Stock Split 2652 4Amarin Provides Business Update and Announces Implementation of Reverse Stock Split 2652 5Amarin Provides Business Update and Announces Implementation of Reverse Stock Split 2652 6Amarin Provides Business Update and Announces Implementation of Reverse Stock Split 2652 7Amarin Provides Business Update and Announces Implementation of Reverse Stock Split 2652 8Amarin Provides Business Update and Announces Implementation of Reverse Stock Split 2652 9Alfacell Announces ONCONASE 28R 29 Purchase and Supply Agreement with Scientific Protein Laboratories 2650 1Alfacell Announces ONCONASE 28R 29 Purchase and Supply Agreement with Scientific Protein Laboratories 2650 2Alfacell Announces ONCONASE 28R 29 Purchase and Supply Agreement with Scientific Protein Laboratories 2650 3
...t instructs cells with fatally damaged DNA to self... If p53 is inactivated, as it is in over half of a...th fail to operate, and body cells start to accumu...r. Not surprisingly, the regulation of this vital ...y years but mainly in tissue culture, or in vitro,...
...ced the approval of Baraclude (entecavir) tablets ...atitis B in adults. Chronic hepatitis B is a serio...hat attacks the liver. The virus can cause lifelon...ver cancer, liver failure, and death. According to...pproximately 1.25 million Americans are chronicall...
...onwealth University Massey Cancer Center, in colla...ing Cancer Center, has identified the crystal stru...nutrients to solid tumors. , This identification m...f the cell signaling that occurs when cancer cells...o feed and spread growing tumors. , The structure...
...of California, Berkeley, and the Harvard School of...efficient technologies for producing charcoal in A...ant climate change and development benefits. , The...ions in Asia and Latin America, is dependent on bo.... In 2000, nearly 470 million tons of wood were co...
Other Biology News:Cancer related gene p53 not regulated as indicated by previous tissue culture research 2Cancer related gene p53 not regulated as indicated by previous tissue culture research 3Study of energy and health in Africa focuses spotlight on charcoal and forest management 2Study of energy and health in Africa focuses spotlight on charcoal and forest management 3
Application: for RNase- decontamination , Registered Trademark of Ambion. ,Special grade: for molecular biology Density: 1.00 g/mL (20 C) Suitab tst: RNase decontamination in accordance
With L-glutamine and potassium bicarbonate. Sterile, Insect cell culture tested
Designed to meet the needs of the biopharmaceutical industry, this animal component-free medium supports fast cell growth rates and high cell densities, while maintaining high cell viability and high
Mol wt: average mol wt12,360.96 Da by calculation
Biology Products: